# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-102289
Filing Date
2022-04-12
Accepted
2022-04-12 06:06:03
Documents
13
Period of Report
2022-05-10

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | d301043ddef14a.htm | DEF 14A | 437265
2 | GRAPHIC | g301043dsp001.jpg | GRAPHIC | 226056
3 | GRAPHIC | g301043dsp002.jpg | GRAPHIC | 144804
4 | GRAPHIC | g301043g10o34.jpg | GRAPHIC | 27019
5 | GRAPHIC | g301043g11i11.jpg | GRAPHIC | 26057
6 | GRAPHIC | g301043g15g55.jpg | GRAPHIC | 26545
7 | GRAPHIC | g301043g22i22.jpg | GRAPHIC | 26232
8 | GRAPHIC | g301043g33i33.jpg | GRAPHIC | 25624
9 | GRAPHIC | g301043g35z31.jpg | GRAPHIC | 24028
10 | GRAPHIC | g301043g44i44.jpg | GRAPHIC | 24536
11 | GRAPHIC | g301043g49q08.jpg | GRAPHIC | 107122
12 | GRAPHIC | g301043g57t78.jpg | GRAPHIC | 51485
13 | GRAPHIC | g301043g69o10.jpg | GRAPHIC | 38750
| Complete submission text file | 0001193125-22-102289.txt |  | 1436863

Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Filer) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36510 | Film No.: 22821039
SIC: 2834 Pharmaceutical Preparations